Do we really Need Lugol Solution in the Era of Energy Devices for the Preoperative Management of Patients with Graves’ Disease?

J Clin Exp Invest 2019;10(4):em00730.

https://doi.org/10.5799/jcei/5904

OPEN ACCESS

Download Full Text (PDF)

Abstract

Introduction: Inorganic iodide (Lugol solution) has been used for the preoperative management of patients with Graves’ disease for many years. However, some new instruments have come into the surgeons reach that can accomplish bloodless operative field without the need of preoperative treatment. The purpose of this prospective study was to evaluate the efficacy and safety in the application of two types of energy devices – SonoSurg® and Thunderbeat® in patients with and without preoperative preparation with Lugol solution.
Material and Methods: The study included 100 patients with Greaves’ disease operated between January 2017 and December 2017. Patients were divided into four groups - 50 patients operated using SonoSurg® - 25 patients with preoperative preparation with Lugol solution and 25 without preoperative PI preparation, and 50 patients operated using Thunderbeat® - 25 patients with and 25 without preoperative Lugol preparation. We evaluated and compared the outcome between the four groups.
Results: The four groups had a similar distribution in the demographic features such as gender, age, and functional activity. When comparing the results, we found very similar results in the groups with preoperative preparation with PI solution. In contrasts we found significant differences in the duration of surgery, intraoperative and postoperative complications between the groups without preoperative PI preparation. Hospital stay of patients in four groups was similar - an average of 2 days stay into the clinic.
Conclusion: Our results showed that Lugol solution preparation has its place in the era of energy devices. Thunderbeat® can accomplish reliable hemostasis without preoperative Lugol preparation however we can achieve the same result with SonoSurg® and preoperative preparation at a much lower cost.

Keywords

Graves’ disease, Thunderbeat, Sonosurg, Lugol solution

References

  • Meng W. [Carl Adolph von Basedow--150th anniversary of his death]. Zeitschrift fur arztliche Fortbildung und Qualitatssicherung. 2004;98 Suppl 5:7-12.
  • Taylor S. Graves of Graves’ disease, 1796-1853. Journal of the Royal College of Physicians of London. 1986;20(4):298-300.
  • McConahey WM PD. Henry Stanley Plummer. . Endocrinology. 1991.
  • Bahn Chair RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid: official journal of the American Thyroid Association. 2011;21(6):593-646.
  • Koyuncu A, Dokmetas HS, Turan M, Aydin C, Karadayi K, Budak E, et al. Comparison of different thyroidectomy techniques for benign thyroid disease. Endocrine journal. 2003;50(6):723-7.
  • Carlander J, Johansson K, Lindstrom S, Velin AK, Jiang CH, Nordborg C. Comparison of experimental nerve injury caused by ultrasonically activated scalpel and electrosurgery. The British journal of surgery. 2005;92(6):772-7.
  • Diamantis T, Kontos M, Arvelakis A, Syroukis S, Koronarchis D, Papalois A, et al. Comparison of monopolar electrocoagulation, bipolar electrocoagulation, Ultracision, and Ligasure. Surgery today. 2006;36(10):908-13.
  • Shinall MC, Broome JT, Baker A, Solorzano CC. Is Potassium Iodide Solution Necessary Before Total Thyroidectomy for Graves Disease? Annals of surgical oncology. 2013;20(9):2964-7.
  • Kwak HY, Dionigi G, Kim D, Lee HY, Son GS, Lee JB, et al. Thermal injury of the recurrent laryngeal nerve by THUNDERBEAT during thyroid surgery: findings from continuous intraoperative neuromonitoring in a porcine model. J Surg Res. 2016;200(1):177-82.
  • Cooper DS. Hyperthyroidism. Lancet. 2003;362(9382):459-68.
  • Burch HB, Cooper DS. Management of graves disease: A review. Jama. 2015;314(23).
  • Abraham P, Avenell A, Park CM, Watson WA, Bevan JS. A systematic review of drug therapy for Graves’ hyperthyroidism. European journal of endocrinology / European Federation of Endocrine Societies. 2005;153(4):489-98.
  • Rossich LE, Thomasz L, Nicola JP, Nazar M, Salvarredi LA, Pisarev M, et al. Effects of 2-iodohexadecanal in the physiology of thyroid cells. Molecular and cellular endocrinology. 2016;437:292-301.
  • Markou K, Georgopoulos N, Kyriazopoulou V, Vagenakis AG. Iodine-Induced hypothyroidism. Thyroid: official journal of the American Thyroid Association. 2001;11(5):501-10.
  • Erbil Y, Ozluk Y, Giris M, Salmaslioglu A, Issever H, Barbaros U, et al. Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves’ disease. The Journal of clinical endocrinology and metabolism. 2007;92(6):2182-9.
  • Castagnone D, Rivolta R, Rescalli S, Baldini MI, Tozzi R, Cantalamessa L. Color Doppler sonography in Graves’ disease: value in assessing activity of disease and predicting outcome. AJR Am J Roentgenol. 1996;166(1):203-7.
  • Hari Kumar KV, Pasupuleti V, Jayaraman M, Abhyuday V, Rayudu BR, Modi KD. Role of thyroid Doppler in differential diagnosis of thyrotoxicosis. Endocr Pract. 2009;15(1):6-9.
  • McCarus SD. Physiologic mechanism of the ultrasonically activated scalpel. The Journal of the American Association of Gynecologic Laparoscopists. 1996;3(4):601-8.
  • Steinemann DC, Lamm SH, Zerz A. Efficacy and Safety of Combined Ultrasonic and Bipolar Energy Source in Laparoscopic Surgery. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract. 2016.
  • Van Slycke S, Gillardin JP, Van Den Heede K, Minguet J, Vermeersch H, Brusselaers N. Comparison of the harmonic focus and the thunderbeat for open thyroidectomy. Langenbeck’s Archives of Surgery. 2016;401(6):851-9.
  • Lombardi CP, Raffaelli M, Cicchetti A, Marchetti M, De Crea C, Di Bidino R, et al. The use of “harmonic scalpel” versus “knot tying” for conventional “open” thyroidectomy: results of a prospective randomized study. Langenbeck’s Archives of Surgery. 2008;393(5):627-31.

Citation

Vidinov KN, Stoinov Y. Do we really Need Lugol Solution in the Era of Energy Devices for the Preoperative Management of Patients with Graves’ Disease?. J Clin Exp Invest. 2019;10(4):em00730. https://doi.org/10.5799/jcei/5904